Regulation of translesion DNA synthesis: Posttranslational modification of lysine residues in key proteins

DNA Repair

Volumn 29, Issue , 2015, Pages 166-179

  McIntyre, Justyna ^a   Woodgate, Roger ^b  

^a INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

PCNA; Translesion synthesis; Ubiquitin; Y family polymerase

Indexed keywords

CYCLINE; DNA DIRECTED DNA POLYMERASE; LYSINE;

AMINO ACID SEQUENCE; DNA REPAIR; DNA REPLICATION; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEOMICS; UBIQUITINATION;

AMINO ACID SEQUENCE; DNA REPAIR; DNA REPLICATION; DNA-DIRECTED DNA POLYMERASE; HUMANS; LYSINE; MOLECULAR SEQUENCE DATA; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEOMICS; UBIQUITINATION;

EID: 84939987001     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2015.02.011     Document Type: Article

References (233)

1. Khoury G.A., Baliban R.C., Floudas C.A. Proteome-wide post-translational modification statistics: frequency analysis and curation of the Swiss-Prot database. Sci. Rep. 2011, 1.
2. Chen Y., Sprung R., Tang Y., Ball H., Sangras B., Kim S.C., Falck J.R., Peng J., Gu W., Zhao Y. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell. Proteomics MCP 2007, 6:812-819.
3. Zhang X., Wen H., Shi X. Lysine methylation: beyond histones. Acta Biochim. Biophys. Sin. 2012, 44:14-27.
4. Lee S. Post-translational modification of proteins in toxicological research: focus on lysine acylation. Toxicol. Res. 2013, 29:81-86.
5. DNA Repair and Mutagenesis 2006, ASM Press, Washington, DC. 2nd ed. E.C. Friedberg, E.C. Friedberg (Eds.).
6. Pinder J.B., Attwood K.M., Dellaire G. Reading, writing, and repair: the role of ubiquitin and the ubiquitin-like proteins in DNA damage signaling and repair. Front. Genet. 2013, 4.
7. Zhao Y., Brickner J.R., Majid M.C., Mosammaparast N. Crosstalk between ubiquitin and other post-translational modifications on chromatin during double-strand break repair. Trends Cell Biol. 2014, 24:426-434.
8. Yang K., Weinacht C.P., Zhuang Z. Regulatory role of ubiquitin in eukaryotic DNA translesion synthesis. Biochemistry 2013, 52:3217-3228.
9. Ulrich H.D. Two-way communications between ubiquitin-like modifiers and DNA. Nat. Struct. Mol. Biol. 2014, 21:317-324.
10. Huang T.T., D'Andrea A.D. Regulation of DNA repair by ubiquitylation. Nat. Rev. Mol. Cell Biol. 2006, 7:323-334.
11. Aguilar R.C., Wendland B. Ubiquitin: not just for proteasomes anymore. Curr. Opin. Cell Biol. 2003, 15:184-190.
12. Haglund K., Di Fiore P.P., Dikic I. Distinct monoubiquitin signals in receptor endocytosis. Trends Biochem. Sci. 2003, 28:598-603.
13. Hicke L. Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell Biol. 2001, 2:195-201.
14. Sun L., Chen Z.J. The novel functions of ubiquitination in signaling. Curr. Opin. Cell Biol. 2004, 16:119-126.
15. Kessler B.M. Ubiquitin-omics reveals novel networks and associations with human disease. Curr. Opin. Chem. Biol. 2013, 17:59-65.
16. Hoeller D., Hecker C.-M., Dikic I. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat. Rev. Cancer 2006, 6:776-788.
17. Ciechanover A., Schwartz A.L. The ubiquitin system: pathogenesis of human diseases and drug targeting. Biochim. Biophys. Acta 2004, 1695:3-17.
18. Reinstein E., Ciechanover A. Narrative review: protein degradation and human diseases: the ubiquitin connection. Ann. Intern. Med. 2006, 145:676-684.
19. Petroski M.D. The ubiquitin system, disease, and drug discovery. BMC Biochem. 2008, 9(Suppl. 1):S7.
20. Nalepa G., Rolfe M., Harper J.W. Drug discovery in the ubiquitin-proteasome system. Nat. Rev. Drug Discov. 2006, 5:596-613.
21. Wong B.R., Parlati F., Qu K., Demo S., Pray T., Huang J., Payan D.G., Bennett M.K. Drug discovery in the ubiquitin regulatory pathway. Drug Discov. Today 2003, 8:746-754.
22. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67:425-479.
23. Ciechanover A., Ben-Saadon R. N-terminal ubiquitination: more protein substrates join in. Trends Cell Biol. 2004, 14:103-106.
24. Cadwell K., Coscoy L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 2005, 309:127-130.
25. Kravtsova-Ivantsiv Y., Sommer T., Ciechanover A. The lysine48-based polyubiquitin chain proteasomal signal: not a single child anymore. Angew. Chem. Int. Ed. 2013, 52:192-198.
26. Jentsch S. Ubiquitin-dependent protein degradation: a cellular perspective. Trends Cell Biol. 1992, 2:98-103.
27. Ciechanover A. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 1998, 17:7151-7160.
28. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 2002, 82:373-428.
29. Kirisako T., Kamei K., Murata S., Kato M., Fukumoto H., Kanie M., Sano S., Tokunaga F., Tanaka K., Iwai K. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 2006, 25:4877-4887.
30. Hofmann R.M., Pickart C.M. In vitro assembly and recognition of Lys-63 polyubiquitin chains. J. Biol. Chem. 2001, 276:27936-27943.
31. Welchman R.L., Gordon C., Mayer R.J. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat. Rev. Mol. Cell Biol. 2005, 6:599-609.
32. Dimova N.V., Hathaway N.A., Lee B.-H., Kirkpatrick D.S., Berkowitz M.L., Gygi S.P., Finley D., King R.W. APC/C-mediated multiple monoubiquitylation provides an alternative degradation signal for cyclin B1. Nat. Cell Biol. 2012, 14:168-176.
33. Dammer E.B., Na C.H., Xu P., Seyfried N.T., Duong D.M., Cheng D., Gearing M., Rees H., Lah J.J., Levey A.I., Rush J., Peng J. Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J. Biol. Chem. 2011, 286:10457-10465.
34. Koegl M., Hoppe T., Schlenker S., Ulrich H.D., Mayer T.U., Jentsch S. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 1999, 96:635-644.
35. Richly H., Rape M., Braun S., Rumpf S., Hoege C., Jentsch S. A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting. Cell 2005, 120:73-84.
36. Amerik A.Y., Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim. Biophys. Acta BBA - Mol. Cell Res. 2004, 1695:189-207.
37. Cajee U.-F., Hull R., Ntwasa M. Modification by ubiquitin-like proteins: significance in apoptosis and autophagy pathways. Int. J. Mol. Sci. 2012, 13:11804-11831.
38. Herrmann J., Lerman L.O., Lerman A. Ubiquitin and ubiquitin-like proteins in protein regulation. Circ. Res. 2007, 100:1276-1291.
39. Meulmeester E., Melchior F. Cell biology: SUMO. Nature 2008, 452:709-711.
40. Hochstrasser M. Origin and function of ubiquitin-like proteins. Nature 2009, 458:422-429.
41. Kerscher O. SUMO junction-what's your function? New insights through SUMO-interacting motifs. EMBO Rep. 2007, 8:550-555.
42. Droescher M., Chaugule V.K., Pichler A. SUMO rules: regulatory concepts and their implication in neurologic functions. Neuromol. Med. 2013, 15:639-660.
43. Bettermann K., Benesch M., Weis S., Haybaeck J. SUMOylation in carcinogenesis. Cancer Lett. 2012, 316:113-125.
44. Krumova P., Weishaupt J.H. Sumoylation in neurodegenerative diseases. Cell. Mol. Life Sci. 2013, 70:2123-2138.
45. Rajan S., Torres J., Thompson M.S., Philipson L.H. SUMO downregulates GLP-1-stimulated cAMP generation and insulin secretion. AJP Endocrinol. Metab. 2012, 302:E714-E723.
46. Haas A.L., Ahrens P., Bright P.M., Ankel H. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J. Biol. Chem. 1987, 262:11315-11323.
47. Zou W., Zhang D.-E. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J. Biol. Chem. 2006, 281:3989-3994.
48. Dastur A., Beaudenon S., Kelley M., Krug R.M., Huibregtse J.M. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J. Biol. Chem. 2006, 281:4334-4338.
49. Jeon Y.J., Yoo H.M., Chung C.H. ISG15 and immune diseases. Biochim. Biophys. Acta BBA - Mol. Basis Dis. 2010, 1802:485-496.
50. Morales D.J., Lenschow D.J. The antiviral activities of ISG15. J. Mol. Biol. 2013, 425:4995-5008.
51. Desai S.D. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res. 2006, 66:921-928.
52. Kamitani T., Kito K., Nguyen H.P., Yeh E.T.H. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J. Biol. Chem. 1997, 272:28557-28562.
53. Whitby F.G., Xia G., Pickart C.M., Hill C.P. Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes. J. Biol. Chem. 1998, 273:34983-34991.
54. Pan Z.-Q., Kentsis A., Dias D.C., Yamoah K., Wu K. Nedd8 on cullin: building an expressway to protein destruction. Oncogene 2004, 23:1985-1997.
55. Xirodimas D.P., Sundqvist A., Nakamura A., Shen L., Botting C., Hay R.T. Ribosomal proteins are targets for the NEDD8 pathway. EMBO Rep. 2008, 9:280-286.
56. Lin D.-H., Sterling H., Wang Z., Babilonia E., Yang B., Dong K., Hebert S.C., Giebisch G., Wang W.-H. ROMK1 channel activity is regulated by monoubiquitination. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4306-4311.
57. Okumoto K., Noda H., Fujiki Y. Distinct modes of ubiquitination of peroxisome-targeting signal type 1 (PTS1)-receptor Pex5p regulate PTS1 protein import. J. Biol. Chem. 2014, 289:14089-14108.
58. Gentry M.S., Worby C.A., Dixon J.E. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8501-8506.
59. Malakhov M.P., Kim K.I., Malakhova O.A., Jacobs B.S., Borden E.C., Zhang D.-E. High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J. Biol. Chem. 2003, 278:16608-16613.
60. Wagner S.A., Beli P., Weinert B.T., Nielsen M.L., Cox J., Mann M., Choudhary C. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell. Proteomics 2011, 10. M111.013284.
61. Danielsen J.M.R., Sylvestersen K.B., Bekker-Jensen S., Szklarczyk D., Poulsen J.W., Horn H., Jensen L.J., Mailand N., Nielsen M.L. Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Mol. Cell. Proteomics 2011, 10. M110.003590.
62. Kim W., Bennett E.J., Huttlin E.L., Guo A., Li J., Possemato A., Sowa M.E., Rad R., Rush J., Comb M.J., Harper J.W., Gygi S.P. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 2011, 44:325-340.
63. Udeshi N.D., Mani D.R., Eisenhaure T., Mertins P., Jaffe J.D., Clauser K.R., Hacohen N., Carr S.A. Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition. Mol. Cell. Proteomics 2012, 11:148-159.
64. Udeshi N.D., Mertins P., Svinkina T., Carr S.A. Large-scale identification of ubiquitination sites by mass spectrometry. Nat. Protoc. 2013, 8:1950-1960.
65. Povlsen L.K., Beli P., Wagner S.A., Poulsen S.L., Sylvestersen K.B., Poulsen J.W., Nielsen M.L., Bekker-Jensen S., Mailand N., Choudhary C. Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat. Cell Biol. 2012, 14:1089-1098.
66. Matic I., Schimmel J., Hendriks I.A., van Santen M.A., van de Rijke F., van Dam H., Gnad F., Mann M., Vertegaal A.C.O. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. Mol. Cell 2010, 39:641-652.
67. Tammsalu T., Matic I., Jaffray E.G., Ibrahim A.F.M., Tatham M.H., Hay R.T. Proteome-wide identification of SUMO2 modification sites. Sci. Signal. 2014, 7:rs2.
68. Chernorudskiy A.L., Garcia A., Eremin E.V., Shorina A.S., Kondratieva E.V., Gainullin M.R. UbiProt: a database of ubiquitylated proteins. BMC Bioinform. 2007, 8:126.
69. Lee W.-C., Lee M., Jung J.W., Kim K.P., Kim D. SCUD. Saccharomyces Cerevisiae Ubiquitination Database. BMC Genomics 2008, 9:440.
70. Li H., Xing X., Ding G., Li Q., Wang C., Xie L., Zeng R., Li Y. SysPTM: a systematic resource for proteomic research on post-translational modifications. Mol. Cell. Proteomics 2009, 8:1839-1849.
71. Liu Z., Wang Y., Gao T., Pan Z., Cheng H., Yang Q., Cheng Z., Guo A., Ren J., Xue Y. CPLM: a database of protein lysine modifications. Nucleic Acids Res. 2014, 42:D531-D536.
72. Catic A., Collins C., Church G.M., Ploegh H.L. Preferred in vivo ubiquitination sites. Bioinformatics 2004, 20:3302-3307.
73. Tung C.-W., Ho S.-Y. Computational identification of ubiquitylation sites from protein sequences. BMC Bioinform. 2008, 9:310.
74. Radivojac P., Vacic V., Haynes C., Cocklin R.R., Mohan A., Heyen J.W., Goebl M.G., Iakoucheva L.M. Identification, analysis, and prediction of protein ubiquitination sites. Proteins Struct. Funct. Bioinform. 2010, 78:365-380.
75. Cai Y., Huang T., Hu L., Shi X., Xie L., Li Y. Prediction of lysine ubiquitination with mRMR feature selection and analysis. Amino Acids 2012, 42:1387-1395.
76. Chen Z., Chen Y.-Z., Wang X.-F., Wang C., Yan R.-X., Zhang Z. Prediction of ubiquitination sites by using the composition of k-spaced amino acid pairs. PLoS ONE 2011, 6:e22930.
77. Chen Z., Zhou Y., Song J., Zhang Z. hCKSAAP_UbSite: improved prediction of human ubiquitination sites by exploiting amino acid pattern and properties. Biochim. Biophys. Acta 2013, 1834:1461-1467.
78. Walsh I., Di Domenico T., Tosatto S.C.E. RUBI: rapid proteomic-scale prediction of lysine ubiquitination and factors influencing predictor performance. Amino Acids 2014, 46:853-862.
79. Chen X., Qiu J.-D., Shi S.-P., Suo S.-B., Huang S.-Y., Liang R.-P. Incorporating key position and amino acid residue features to identify general and species-specific ubiquitin conjugation sites. Bioinformatics (Oxf., Engl.) 2013, 29:1614-1622.
80. Sampson D.A., Wang M., Matunis M.J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 2001, 276:21664-21669.
81. Zhao Q., Xie Y., Zheng Y., Jiang S., Liu W., Mu W., Liu Z., Zhao Y., Xue Y., Ren J. GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs. Nucleic Acids Res. 2014, 42:W325-W330.
82. Xue Y., Zhou F., Zhu M., Ahmed K., Chen G., Yao X. GPS: a comprehensive www server for phosphorylation sites prediction. Nucleic Acids Res. 2005, 33:W184-W187.
83. Xue Y., Zhou F., Fu C., Xu Y., Yao X. SUMOsp: a web server for sumoylation site prediction. Nucleic Acids Res. 2006, 34:W254-W257.
84. Zhou F.-F., Xue Y., Chen G.-L., Yao X. GPS: a novel group-based phosphorylation predicting and scoring method. Biochem. Biophys. Res. Commun. 2004, 325:1443-1448.
85. Kim J.H., Lee J., Oh B., Kimm K., Koh I. Prediction of phosphorylation sites using SVMs. Bioinformatics 2004, 20:3179-3184.
86. Ren J., Gao X., Jin C., Zhu M., Wang X., Shaw A., Wen L., Yao X., Xue Y. Systematic study of protein sumoylation: development of a site-specific predictor of SUMOsp 2.0. Proteomics 2009, 9:3409-3412.
87. Teng S., Luo H., Wang L. Predicting protein sumoylation sites from sequence features. Amino Acids 2012, 43:447-455.
88. Schwartz D. Prediction of lysine post-translational modifications using bioinformatic tools. Essays Biochem. 2012, 52:165-177.
89. Emanuele M.J., Elia A.E.H., Xu Q., Thoma C.R., Izhar L., Leng Y., Guo A., Chen Y.-N., Rush J., Hsu P.W.-C., Yen H.-C.S., Elledge S.J. Global identification of modular cullin-RING ligase substrates. Cell 2011, 147:459-474.
90. Lopitz-Otsoa F., Rodriguez-Suarez E., Aillet F., Casado-Vela J., Lang V., Matthiesen R., Elortza F., Rodriguez M.S. Integrative analysis of the ubiquitin proteome isolated using Tandem Ubiquitin Binding Entities (TUBEs). J. Proteomics 2012, 75:2998-3014.
91. Meierhofer D., Wang X., Huang L., Kaiser P. Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry. J. Proteome Res. 2008, 7:4566-4576.
92. Mertins P., Qiao J.W., Patel J., Udeshi N.D., Clauser K.R., Mani D.R., Burgess M.W., Gillette M.A., Jaffe J.D., Carr S.A. Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat. Methods 2013, 10:634-637.
93. Xu G., Deglincerti A., Paige J.S., Jaffrey S.R. Profiling lysine ubiquitination by selective enrichment of ubiquitin remnant-containing peptides. Methods Mol. Biol. (Clifton, NJ) 2014, 1174:57-71.
94. Vertegaal A.C.O., Andersen J.S., Ogg S.C., Hay R.T., Mann M., Lamond A.I. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell. Proteomics 2006, 12:2298-2310.
95. Bursomanno S., Beli P., Khan A.M., Minocherhomji S., Wagner S.A., Bekker-Jensen S., Mailand N., Choudhary C., Hickson I.D., Liu Y. Proteome-wide analysis of SUMO2 targets in response to pathological DNA replication stress in human cells. DNA Repair 2015, 25:84-96.
96. Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M., Vertegaal A.C. Uncovering global SUMOylation signaling networks in a site-specific manner. Nat. Struct. Mol. Biol. 2014, 10:927-936.
97. Makarov A., Denisov E., Kholomeev A., Balschun W., Lange O., Strupat K., Horning S. Performance evaluation of a hybrid linear ion trap/orbitrap mass spectrometer. Anal. Chem. 2006, 78:2113-2120.
98. Zubarev R., Mann M. On the proper use of mass accuracy in proteomics. Mol. Cell. Proteomics 2007, 6:377-381.
99. Marshall A.G., Hendrickson C.L. High-resolution mass spectrometers. Annu. Rev. Anal. Chem. 2008, 1:579-599.
100. Peng J., Elias J.E., Thoreen C.C., Licklider L.J., Gygi S.P. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J. Proteome Res. 2003, 2:43-50.
101. Franco M., Seyfried N.T., Brand A.H., Peng J., Mayor U. A novel strategy to isolate ubiquitin conjugates reveals wide role for ubiquitination during neural development. Mol. Cell. Proteomics 2011, 10. M110.002188.
102. Xu G., Paige J.S., Jaffrey S.R. Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat. Biotechnol. 2010, 28:868-873.
103. Matsumoto M.L., Wickliffe K.E., Dong K.C., Yu C., Bosanac I., Bustos D., Phu L., Kirkpatrick D.S., Hymowitz S.G., Rape M., Kelley R.F., Dixit V.M. K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. Mol. Cell 2010, 39:477-484.
104. Shi Y., Chan D.W., Jung S.Y., Malovannaya A., Wang Y., Qin J. A data set of human endogenous protein ubiquitination sites. Mol. Cell. Proteomics 2011, 10. M110.002089.
105. Shi Y., Xu P., Qin J. Ubiquitinated proteome: ready for global?. Mol. Cell. Proteomics 2011, 10. R110.006882.
106. Hjerpe R., Thomas Y., Kurz T. NEDD8 overexpression results in neddylation of ubiquitin substrates by the ubiquitin pathway. J. Mol. Biol. 2012, 421:27-29.
107. Matsumoto M.L., Dong K.C., Yu C., Phu L., Gao X., Hannoush R.N., Hymowitz S.G., Kirkpatrick D.S., Dixit V.M., Kelley R.F. Engineering and structural characterization of a linear polyubiquitin-specific antibody. J. Mol. Biol. 2012, 418:134-144.
108. Lee K.A., Hammerle L.P., Andrews P.S., Stokes M.P., Mustelin T., Silva J.C., Black R.A., Doedens J.R. Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels. J. Biol. Chem. 2011, 286:41530-41538.
109. Sarraf S.A., Raman M., Guarani-Pereira V., Sowa M.E., Huttlin E.L., Gygi S.P., Harper J.W. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 2013, 496:372-376.
110. Stes E., Laga M., Walton A., Samyn N., Timmerman E., De Smet I., Goormachtig S., Gevaert K. A COFRADIC protocol to study protein ubiquitination. J. Proteome Res. 2014, 13:3107-3113.
111. Golebiowski F., Matic I., Tatham M.H., Cole C., Yin Y., Nakamura A., Cox J., Barton G.J., Mann M., Hay R.T. System-wide changes to SUMO modifications in response to heat shock. Sci. Signal. 2009, 72:ra24.
112. Bruderer R., Tatham M.H., Plechanovova A., Matic I., Garg A.K., Hay R.T. Purification and identification of endogenous polySUMO conjugates. EMBO Rep. 2011, 12:142-148.
113. Becker J., Barysch S.V., Karaca S., Dittner C., Hsiao H.H., Berriel Diaz M., Herzig S., Urlaub H., Melchior F. Detecting endogenous SUMO targets in mammalian cells and tissues. Nat. Struct. Mol. Biol. 2013, 20:525-531.
114. Zhao Y., Kwon S.W., Anselmo A., Kaur K., White M.A. Broad spectrum identification of cellular small ubiquitin-related modifier (SUMO) substrate proteins. J. Biol. Chem. 2004, 279:20999-21002.
115. Filosa G., Barabino S.M.L., Bachi A. Proteomics strategies to identify SUMO targets and acceptor sites: a survey of RNA-binding proteins SUMOylation. Neuromol. Med. 2013, 15:661-676.
116. Wilson V.G., Heaton P.R. Ubiquitin proteolytic system: focus on SUMO. Expert Rev. Proteomics 2008, 5:121-135.
117. Chicooree N., Griffiths J.R., Connolly Y., Tan C.-T., Malliri A., Eyers C.E., Smith D.L. A novel approach to the analysis of SUMOylation with the independent use of trypsin and elastase digestion followed by database searching utilising consecutive residue addition to lysine. Rapid Commun. Mass Spectrom. 2013, 27:127-134.
118. Jones J., Wu K., Yang Y., Guerrero C., Nillegoda N., Pan Z.-Q., Huang L. A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. J. Proteome Res. 2008, 7:1274-1287.
119. Zhao C., Denison C., Huibregtse J.M., Gygi S., Krug R.M. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:10200-10205.
120. Lopes M., Foiani M., Sogo J.M. Multiple mechanisms control chromosome integrity after replication fork uncoupling and restart at irreparable UV lesions. Mol. Cell 2006, 21:15-27.
121. Branzei D. Ubiquitin family modifications and template switching. FEBS Lett. 2011, 585:2810-2817.
122. Xiao W., Chow B.L., Broomfield S., Hanna M. The Saccharomyces cerevisiae RAD6 group is composed of an error-prone and two error-free postreplication repair pathways. Genetics 2000, 155:1633-1641.
123. Broomfield S., Hryciw T., Xiao W. DNA postreplication repair and mutagenesis in Saccharomyces cerevisiae. Mutat. Res. 2001, 486:167-184.
124. Woodgate R. Evolution of the two-step model for UV-mutagenesis. Mutat. Res. 2001, 485:83-92.
125. Krishna T.S., Kong X.P., Gary S., Burgers P.M., Kuriyan J. Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA. Cell 1994, 79:1233-1243.
126. Kirchmaier A.L. Ub-family modifications at the replication fork: regulating PCNA-interacting components. FEBS Lett. 2011, 585:2920-2928.
127. Warbrick E. The puzzle of PCNA's many partners. BioEssays News Rev. Mol. Cell. Dev. Biol. 2011, 22:997-1006.
128. Moldovan G.-L., Pfander B., Jentsch S. PCNA, the maestro of the replication fork. Cell 2007, 129:665-679.
129. Hoege C., Pfander B., Moldovan G.-L., Pyrowolakis G., Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 2002, 419:135-141.
130. Parker J.L., Ulrich H.D. Mechanistic analysis of PCNA poly-ubiquitylation by the ubiquitin protein ligases Rad18 and Rad5. EMBO J. 2009, 28:3657-3666.
131. Arakawa H., Moldovan G.-L., Saribasak H., Saribasak N.N., Jentsch S., Buerstedde J.-M. A role for PCNA ubiquitination in immunoglobulin hypermutation. PLoS Biol. 2006, 4:e366.
132. Simpson L.J., Ross A.-L., Szüts D., Alviani C.A., Oestergaard V.H., Patel K.J., Sale J.E. RAD18-independent ubiquitination of proliferating-cell nuclear antigen in the avian cell line DT40. EMBO Rep. 2006, 7:927-932.
133. Kats E.S., Enserink J.M., Martinez S., Kolodner R.D. The Saccharomyces cerevisiae Rad6 postreplication repair and Siz1/Srs2 homologous recombination-inhibiting pathways process DNA damage that arises in asf1 mutants. Mol. Cell. Biol. 2009, 29:5226-5237.
134. Terai K., Abbas T., Jazaeri A.A., Dutta A. CRL4(Cdt2) E3 ubiquitin ligase monoubiquitinates PCNA to promote translesion DNA synthesis. Mol. Cell 2010, 37:143-149.
135. Zhang S., Chea J., Meng X., Zhou Y., Lee E.Y.C., Lee M.Y.W.T. PCNA is ubiquitinated by RNF8. Cell Cycle (Georgetown, Tex.) 2008, 7:3399-3404.
136. Huang T.T., Nijman S.M.B., Mirchandani K.D., Galardy P.J., Cohn M.A., Haas W., Gygi S.P., Ploegh H.L., Bernards R., D'Andrea A.D. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat. Cell Biol. 2006, 8:339-347.
137. Niimi A., Brown S., Sabbioneda S., Kannouche P.L., Scott A., Yasui A., Green C.M., Lehmann A.R. Regulation of proliferating cell nuclear antigen ubiquitination in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:16125-16130.
138. Brun J., Chiu R.K., Wouters B.G., Gray D.A. Regulation of PCNA polyubiquitination in human cells. BMC Res. Notes 2010, 3.
139. Whitehurst C.B., Vaziri C., Shackelford J., Pagano J.S. Epstein-Barr virus BPLF1 deubiquitinates PCNA and attenuates polymerase η recruitment to DNA damage sites. J. Virol. 2012, 86:8097-8106.
140. Motegi A., Sood R., Moinova H., Markowitz S.D., Liu P.P., Myung K. Human SHPRH suppresses genomic instability through proliferating cell nuclear antigen polyubiquitination. J. Cell Biol. 2006, 175:703-708.
141. Motegi A., Liaw H.-J., Lee K.-Y., Roest H.P., Maas A., Wu X., Moinova H., Markowitz S.D., Ding H., Hoeijmakers J.H.J., Myung K. Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic instability from stalled replication forks. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:12411-12416.
142. Unk I., Hajdú I., Fátyol K., Szakál B., Blastyák A., Bermudez V.J., Hurwitz J., Prakash L., Prakash S., Haracska L. Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-dependent polyubiquitylation of proliferating cell nuclear antigen. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18107-18112.
143. Unk I., Hajdú I., Fátyol K., Hurwitz J., Yoon J., Prakash L., Prakash S., Haracska L. Human HLTF functions as a ubiquitin ligase for proliferating cell nuclear antigen polyubiquitination. PNAS 2008, 105:3768-3773.
144. Lin J.-R., Zeman M.K., Chen J.-Y., Yee M.-C., Cimprich K.A. SHPRH and HLTF act in a damage-specific manner to coordinate different forms of postreplication repair and prevent mutagenesis. Mol. Cell 2011, 48:237-249.
145. Krijger P.H., Lee K.Y., Wit N., van den Berk P.C., Wu X., Roest H.P., Maas A., Ding J.H., Hoeijmakers J.H., Myung K., Jacobs H. HLTF and SHPRH are not essential for PCNA polyubiquitination, survival and somatic hypermutation: existence of an alternative E3 ligase. DNA Repair 2011, 10:438-444.
146. Brun J., Chiu R., Lockhart K., Xiao W., Wouters B.G., Gray D.A. hMMS2 serves a redundant role in human PCNA polyubiquitination. BMC Mol. Biol. 2008, 9:9-24.
147. Yu Y., Cai J.-P., Tu B., Wu L., Zhao Y., Liu X., Li L., McNutt M.A., Feng J., He Q., Yang Y., Wang H., Sekiguchi M., Zhu W.-G. Proliferating cell nuclear antigen is protected from degradation by forming a complex with MutT Homolog2. J. Biol. Chem. 2009, 284:19310-19320.
148. Groehler A.L., Lannigan D.A. A chromatin-bound kinase, ERK8, protects genomic integrity by inhibiting HDM2-mediated degradation of the DNA clamp PCNA. J. Cell Biol. 2010, 190:575-586.
149. Yang Q., Ou C., Liu M., Xiao W., Wen C., Sun F. NRAGE promotes cell proliferation by stabilizing PCNA in a ubiquitin-proteasome pathway in esophageal carcinomas. Carcinogenesis 2014, 35:1643-1651.
150. Das-Bradoo S., Nguyen H.D., Wood J.L., Ricke R.M., Haworth J.C., Bielinsky A.-K. Defects in DNA ligase I trigger PCNA ubiquitylation at Lys 107. Nat. Cell Biol. 2010, 12:74-79.
151. Leach C.A., Michael W.M. Ubiquitin/SUMO modification of PCNA promotes replication fork progression in Xenopus laevis egg extracts. J. Cell Biol. 2005, 171:947-954.
152. Gali H., Juhasz S., Morocz M., Hajdu I., Fatyol K., Szukacsov V., Burkovics P., Haracska L. Role of SUMO modification of human PCNA at stalled replication fork. Nucleic Acids Res. 2012, 40:6049-6059.
153. Moldovan G.-L., Dejsuphong D., Petalcorin M.I.R., Hofmann K., Takeda S., Boulton S.J., D'Andrea A.D. Inhibition of homologous recombination by the PCNA-interacting protein PARI. Mol. Cell 2012, 45:75-86.
154. Panse V.G., Küster B., Gerstberger T., Hurt E. Unconventional tethering of Ulp1 to the transport channel of the nuclear pore complex by karyopherins. Nat. Cell Biol. 2003, 5:21-27.
155. Papouli E., Chen S., Davies A.A., Huttner D., Krejci L., Sung P., Ulrich H.D. Crosstalk between SUMO and ubiquitin on PCNA is mediated by recruitment of the helicase Srs2p. Mol. Cell 2005, 19:123-133.
156. Kim S.O., Yoon H., Park S.O., Lee M., Shin J.-S., Ryu K.-S., Lee J.-O., Seo Y.-S., Jung H.S., Choi B.-S. Srs2 possesses a non-canonical PIP box in front of its SBM for precise recognition of SUMOylated PCNA. J. Mol. Cell Biol. 2012, 4:258-261.
157. Kubota T., Nishimura K., Kanemaki M.T., Donaldson A.D. The Elg1 replication factor C-like complex functions in PCNA unloading during DNA replication. Mol. Cell 2013, 50:273-280.
158. Parnas O., Zipin-Roitman A., Pfander B., Liefshitz B., Mazor Y., Ben-Aroya S., Jentsch S., Kupiec M. Elg1, an alternative subunit of the RFC clamp loader, preferentially interacts with SUMOylated PCNA. EMBO J. 2010, 29:2611-2622.
159. Lee K.Y., Yang K., Cohn M.A., Sikdar N., D'Andrea A.D., Myung K. Human ELG1 regulates the level of ubiquitinated proliferating cell nuclear antigen (PCNA) through Its interactions with PCNA and USP1. J. Biol. Chem. 2010, 285:10362-10369.
160. Lee K.Y., Fu H., Aladjem M.I., Myung K. ATAD5 regulates the lifespan of DNA replication factories by modulating PCNA level on the chromatin. J. Cell Biol. 2013, 200:31-44.
161. Skibbens R.V. Establishment of sister chromatid cohesion. Curr. Biol. 2009, 19:R1126-R1132.
162. Park J.M., Yang S.W., Yu K.R., Ka S.H., Lee S.W., Seol J.H., Jeon Y.J., Chung C.H. Modification of PCNA by ISG15 plays a crucial role in termination of error-prone translesion DNA synthesis. Mol. Cell 2014, 54:626-638.
163. Caron C., Boyault C., Khochbin S. Regulatory cross-talk between lysine acetylation and ubiquitination: role in the control of protein stability. BioEssays News Rev. Mol. Cell. Dev. Biol. 2005, 27 4:408-415.
164. Naryzhny S.N., Lee H. The post-translational modifications of proliferating cell nuclear antigen: acetylation, not phosphorylation, plays an important role in the regulation of its function. J. Biol. Chem. 2004, 279:20194-20199.
165. Zhang Z., Zhang S., Lin S.H.S., Wang X., Wu L., Lee E.Y.C., Lee M.Y.W.T. Structure of monoubiquitinated PCNA: implications for DNA polymerase switching and Okazaki fragment maturation. Cell Cycle (Georgetown, Tex.) 2012, 11:2128-2136.
166. Kim B.J., Lee H. Lys-110 is essential for targeting PCNA to replication and repair foci, and the K110A mutant activates apoptosis. Biol. Cell 2008, 100:675-686.
167. Goodman M.F., Woodgate R. Translesion DNA polymerases. Cold Spring Harb. Perspect. Biol. 2013, 5. a010363.
168. Waters L.S., Minesinger B.K., Wiltrout M.E., D'Souza S., Woodruff R.V., Walker G.C. Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance. Microbiol. Mol. Biol. Rev. 2009, 73:134-154.
169. Bienko M., Green C.M., Crosetto N., Rudolf F., Zapart G., Coull B., Kannouche P., Wider G., Peter M., Lehmann A.R., Hofmann K., Dikic I. Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis. Science 2005, 310:1821-1824.
170. Bomar M.G., D'Souza S., Bienko M., Dikic I., Walker G.C., Zhou P. Unconventional ubiquitin recognition by the ubiquitin-binding motif within the Y Family DNA polymerases ι and Rev1. Mol. Cell 2010, 37:408-417.
171. Bienko M., Green C.M., Sabbioneda S., Crosetto N., Matic I., Hibbert R.G., Begovic T., Niimi A., Mann M., Lehmann A.R., Dikic I. Regulation of translesion synthesis DNA polymerase η by monoubiquitination. Mol. Cell 2010, 37:396-407.
172. Skoneczna A., McIntyre J., Skoneczny M., Policinska Z., Sledziewska-Gojska E. Polymerase eta is a short-lived, proteasomally degraded protein that is temporarily stabilized following UV irradiation in Saccharomyces cerevisiae. J. Mol. Biol. 2007, 366:1074-1086.
173. Pabla R., Rozario D., Siede W. Regulation of Saccharomyces cerevisiae DNA polymerase η transcript and protein. Radiat. Environ. Biophys. 2008, 47:157-168.
174. Kim S.-H., Michael W.M. Regulated proteolysis of DNA polymerase eta during the DNA damage response in C. elegans. Mol. Cell 2008, 32:757-766.
175. Parker J.L., Bielen A.B., Dikic I., Ulrich H.D. Contributions of ubiquitin- and PCNA-binding domains to the activity of Polymerase η in Saccharomyces cerevisiae. Nucleic Acids Res. 2007, 35:881-889.
176. Guo C., Tang T.-S., Bienko M., Parker J.L., Bielen A.B., Sonoda E., Takeda S., Ulrich H.D., Dikic I., Friedberg E.C. Ubiquitin-binding motifs in REV1 protein are required for its role in the tolerance of DNA damage. Mol. Cell. Biol. 2006, 26:8892-8900.
177. Guo C., Tang T.S., Bienko M., Dikic I., Friedberg E.C. Requirements for the interaction of mouse Polκ with ubiquitin and its biological significance. J. Biol. Chem. 2008, 283:4658-4664.
178. Hoeller D., Crosetto N., Blagoev B., Raiborg C., Tikkanen R., Wagner S., Kowanetz K., Breitling R., Mann M., Stenmark H., Dikic I. Regulation of ubiquitin-binding proteins by monoubiquitination. Nat. Cell Biol. 2006, 8:163-169.
179. Hoeller D., Hecker C.-M., Wagner S., Rogov V., Dötsch V., Dikic I. E3-independent monoubiquitination of ubiquitin-binding proteins. Mol. Cell 2007, 26:891-898.
180. Haglund K., Stenmark H. Working out coupled monoubiquitination. Nat. Cell Biol. 2006, 8:1218-1219.
181. Roerink S.F., Koole W., Stapel L.C., Romeijn R.J., Tijsterman M. A Broad requirement for TLS polymerases η and κ, and interacting sumoylation and nuclear pore proteins, in lesion bypass during C. elegans embryogenesis. PLoS Genet. 2012, 8:e1002800.
182. Masutani C., Kusumoto R., Yamada A., Dohmae N., Yokoi M., Yuasa M., Araki M., Iwai S., Takio K., Hanaoka F. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η. Nature 1999, 399:700-704.
183. Johnson R.E., Washington M.T., Prakash S., Prakash L. Fidelity of human DNA polymerase η. J. Biol. Chem. 2000, 275:7447-7450.
184. Jung Y.-S., Liu G., Chen X. Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation. Mol. Cell. Biol. 2010, 30:1041-1048.
185. Jung Y.-S., Hakem A., Hakem R., Chen X. Pirh2 E3 ubiquitin ligase monoubiquitinates DNA polymerase eta to suppress translesion DNA synthesis. Mol. Cell. Biol. 2011, 31:3997-4006.
186. Jung Y.-S., Qian Y., Chen X. DNA polymerase eta is targeted by Mdm2 for polyubiquitination and proteasomal degradation in response to ultraviolet irradiation. DNA Repair 2012, 11:177-184.
187. Wallace H.A., Merkle J.A., Yu M.C., Berg T.G., Lee E., Bosco G., Lee L.A. TRIP/NOPO E3 ubiquitin ligase promotes ubiquitylation of DNA polymerase η. Development (Camb., Engl.) 2014, 141:1332-1341.
188. Merkle J.A., Rickmyre J.L., Garg A., Loggins E.B., Jodoin J.N., Lee E., Wu L.P., Lee L.A. No poles encodes a predicted E3 ubiquitin ligase required for early embryonic development of Drosophila. Development (Camb., Engl.) 2009, 136:449-459.
189. Qian J., Pentz K., Zhu Q., Wang Q., He J., Srivastava A.K., Wani A.A. USP7 modulates UV-induced PCNA monoubiquitination by regulating DNA polymerase eta stability. Oncogene 2014, [Epub ahead of print].
190. Plachta M., Halas A., McIntyre J., Sledziewska-Gojska E. The steady-state level and stability of TLS polymerase eta are cell cycle dependent in the yeast S. cerevisiae. DNA Repair 2015, 29:147-153.
191. Chen Y.W., Cleaver J.E., Hatahet Z., Honkanen R.E., Chang J.-Y., Yen Y., Chou K.M. Human DNA polymerase η activity and translocation is regulated by phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:16578-16583.
192. Gohler T., Sabbioneda S., Green C.M., Lehmann A.R. ATR-mediated phosphorylation of DNA polymerase η is needed for efficient recovery from UV damage. J. Cell Biol. 2011, 192:219-227.
193. McDonald J.P., Rapić-Otrin V., Epstein J.A., Broughton B.C., Wang X., Lehmann A.R., Wolgemuth D.J., Woodgate R. Novel human and mouse homologs of Saccharomyces cerevisiae DNA polymerase η. Genomics 1999, 60:20-30.
194. Wang Y., Woodgate R., McManus T.P., Mead S., McCormick J.J., Maher V.M. Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase η, DNA polymerase ι causes the very high frequency and unique spectrum of UV-induced mutations. Cancer Res. 2007, 67:3018-3026.
195. Ohkumo T., Kondo Y., Yokoi M., Tsukamoto T., Yamada A., Sugimoto T., Kanao R., Higashi Y., Kondoh H., Tatematsu M., Masutani C., Hanaoka F. UV-B radiation induces epithelial tumors in mice lacking DNA polymerase η and mesenchymal tumors in mice deficient for DNA polymerase ι. Mol. Cell. Biol. 2006, 26:7696-7706.
196. Wang M., Devereux T.R., Vikis H.G., McCulloch S.D., Holliday W., Anna C., Wang Y., Bebenek K., Kunkel T.A., Guan K., You M. Pol ι is a candidate for the mouse pulmonary adenoma resistance 2 locus, a major modifier of chemically induced lung neoplasia. Cancer Res. 2004, 64:1924-1931.
197. Ziv O., Geacintov N., Nakajima S., Yasui A., Livneh Z. DNA polymerase ζ cooperates with polymerases κ and ι in translesion DNA synthesis across pyrimidine photodimers in cells from XPV patients. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:11552-11557.
198. Jansen J.G., Temviriyanukul P., Wit N., Delbos F., Reynaud C.-A., Jacobs H., de Wind N. Redundancy of mammalian Y family DNA polymerases in cellular responses to genomic DNA lesions induced by ultraviolet light. Nucleic Acids Res. 2014, 42:11071-11082.
199. Frank E.G., Woodgate R. Increased catalytic activity and altered fidelity of human DNA polymerase ι in the presence of manganese. J. Biol. Chem. 2007, 282:24689-24696.
200. Tissier A., Frank E.G., McDonald J.P., Iwai S., Hanaoka F., Woodgate R. Misinsertion and bypass of thymine-thymine dimers by human DNA polymerase ι. EMBO J. 2000, 19:5259-5266.
201. Pence M.G., Blans P., Zink C.N., Hollis T., Fishbein J.C., Perrino F.W. Lesion bypass of N2-ethylguanine by human DNA polymerase ι. J. Biol. Chem. 2009, 284:1732-1740.
202. Washington M.T., Minko I.G., Johnson R.E., Wolfle W.T., Harris T.M., Lloyd R.S., Prakash S., Prakash L. Efficient and error-free replication past a minor-groove DNA adduct by the sequential action of human DNA polymerases ι and κ. Mol. Cell. Biol. 2004, 24:5687-5693.
203. Washington M.T., Carlson K.D., Freudenthal B.D., Pryor J.M. Variations on a theme: eukaryotic Y-family DNA polymerases. Biochim. Biophys. Acta 2010, 1804:1113-1123.
204. Tissier A., Frank E.G., McDonald J.P., Vaisman A., Fernàndez de Henestrosa A.R., Boudsocq F., McLenigan M.P., Woodgate R. Biochemical characterization of human DNA polymerase ι provides clues to its biological function. Biochem. Soc. Trans. 2001, 29:183-187.
205. Zhang Y., Yuan F., Wu X., Wang Z. Preferential incorporation of G opposite template T by the low-fidelity human DNA polymerase ι. Mol. Cell. Biol. 2000, 20:7099-7108.
206. Kirouac K.N., Ling H. Unique active site promotes error-free replication opposite an 8-oxo-guanine lesion by human DNA polymerase iota. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:3210-3215.
207. Nair D.T., Johnson R.E., Prakash L., Prakash S., Aggarwal A.K. Human DNA polymerase ι incorporates dCTP opposite template G via a G.C.+Hoogsteen base pair. Structure 2005, 13:1569-1577.
208. Bebenek K., Tissier A., Frank E.G., McDonald J.P., Prasad R., Wilson S.H., Woodgate R., Kunkel T.A. 5'-Deoxyribose phosphate lyase activity of human DNA polymerase ι in vitro. Science 2001, 291:2156-2159.
209. Prasad R., Bebenek K., Hou E., Shock D.D., Beard W.A., Woodgate R., Kunkel T.A., Wilson S.H. Localization of the deoxyribose phosphate lyase active site in human DNA polymerase ι by controlled proteolysis. J. Biol. Chem. 2003, 278:29649-29654.
210. McIntyre J., Vidal A.E., McLenigan M.P., Bomar M.G., Curti E., McDonald J.P., Plosky B.S., Ohashi E., Woodgate R. Ubiquitin mediates the physical and functional interaction between human DNA polymerases η and ι. Nucleic Acids Res. 2013, 41:1649-1660.
211. Ohashi E., Ogi T., Kusumoto R., Iwai S., Masutani C., Hanaoka F., Ohmori H. Error-prone bypass of certain DNA lesions by the human DNA polymerase κ. Genes Dev. 2000, 14:1589-1594.
212. Lone S., Townson S.A., Uljon S.N., Johnson R.E., Brahma A., Nair D.T., Prakash S., Prakash L., Aggarwal A.K. Human DNA polymerase κ encircles DNA: implications for mismatch extension and lesion bypass. Mol. Cell 2007, 25:601-614.
213. Washington M.T., Johnson R.E., Prakash L., Prakash S. Human DINB1-encoded DNA polymerase κ is a promiscuous extender of mispaired primer termini. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:1910-1914.
214. Ogi T., Lehmann A.R. The Y-family DNA polymerase κ (pol κ) functions in mammalian nucleotide-excision repair. Nat. Cell Biol. 2006, 8:640-642.
215. Sale J.E., Lehmann A.R., Woodgate R. Y-family DNA polymerases and their role in tolerance of cellular DNA damage. Nat. Rev. Mol. Cell Biol. 2012, 13:141-152.
216. Okada T., Sonoda E., Yamashita Y.M., Koyoshi S., Tateishi S., Yamaizumi M., Takata M., Ogawa O., Takeda S. Involvement of vertebrate polκ in Rad18-independent postreplication repair of UV damage. J. Biol. Chem. 2002, 277:48690-48695.
217. Wit N., Buoninfante O.A., van den Berk P.C., Jansen J.G., Hogenbirk M.A., de Wind N., Jacobs H. Roles of PCNA ubiquitination and TLS polymerases κ and η in the bypass of methyl methanesulfonate-induced DNA damage. Nucleic Acids Res. 2015, 43:282-294.
218. Nelson J.R., Lawrence C.W., Hinkle D.C. Deoxycytidyl transferase activity of yeast REV1 protein. Nature 1996, 382:729-731.
219. Nelson J.R., Gibbs P.E., Nowicka A.M., Hinkle D.C., Lawrence C.W. Evidence for a second function for Saccharomyces cerevisiae Rev1p. Mol. Microbiol. 2000, 37:549-554.
220. Lin W., Xin H., Zhang Y., Wu X., Yuan F., Wang Z. The human REV1 gene codes for a DNA template-dependent dCMP transferase. Nucleic Acids Res. 1999, 27:4468-4475.
221. Zhang Y. Response of human REV1 to different DNA damage: preferential dCMP insertion opposite the lesion. Nucleic Acids Res. 2002, 30:1630-1638.
222. Ross A.-L. Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains of REV1. Nucleic Acids Res. 2005, 33:1280-1289.
223. Ohashi E., Murakumo Y., Kanjo N., Akagi J.-I., Masutani C., Hanaoka F., Ohmori H. Interaction of hREV1 with three human Y-family DNA polymerases. Genes Cells 2004, 9:523-531.
224. Ohashi E., Hanafusa T., Kamei K., Song I., Tomida J., Hashimoto H., Vaziri C., Ohmori H. Identification of a novel REV1-interacting motif necessary for DNA polymerase κ function. Genes Cells 2009, 14:101-111.
225. Guo C., Fischhaber P.L., Luk-Paszyc M.J., Masuda Y., Zhou J., Kamiya K., Kisker C., Friedberg E.C. Mouse Rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesis. EMBO J. 2003, 22:6621-6630.
226. Tissier A., Kannouche P., Reck M.-P., Lehmann A.R., Fuchs R.P.P., Cordonnier A. Co-localization in replication foci and interaction of human Y-family members, DNA polymerase pol η and REV1 protein. DNA Repair 2004, 3:1503-1514.
227. Pozhidaeva A., Pustovalova Y., D'Souza S., Bezsonova I., Walker G.C., Korzhnev D.M. NMR structure and dynamics of the C-terminal domain from human Rev1 and its complex with Rev1 interacting region of DNA polymerase η. Biochemistry 2012, 51:5506-5520.
228. Wood A., Garg P., Burgers P.M.J. A ubiquitin-binding motif in the translesion DNA polymerase Rev1 mediates its essential functional interaction with ubiquitinated proliferating cell nuclear antigen in response to DNA damage. J. Biol. Chem. 2007, 282:20256-20263.
229. Pustovalova Y., Maciejewski M.W., Korzhnev D.M. NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain. J. Mol. Biol. 2013, 425:3091-3105.
230. Guo C., Sonoda E., Tang T., Parker J., Bielen A., Takeda S., Ulrich H., Friedberg E. REV1 protein interacts with PCNA: significance of the REV1 BRCT domain in vitro and in vivo. Mol. Cell 2006, 23:265-271.
231. Kim H., Yang K., Dejsuphong D., D'Andrea A.D. Regulation of Rev1 by the Fanconi anemia core complex. Nat. Struct. Mol. Biol. 2012, 19:164-170.
232. Wiltrout M.E., Walker G.C. Proteasomal regulation of the mutagenic translesion DNA polymerase, Saccharomyces cerevisiae Rev1. DNA Repair 2011, 10:169-175.
233. Weinert B.T., Wagner S.A., Horn H., Henriksen P., Liu W.R., Olsen J.V., Jensen L.J., Choudhary C. Proteome-wide mapping of the Drosophila acetylome demonstrates a high degree of conservation of lysine acetylation. Sci. Signal. 2011, 4:ra48.